BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shebl RI. Anti-cancer Potential of Captopril and Botulinum Toxin Type-A and Associated p53 Gene Apototic Stimulating Activity. Iran J Pharm Res 2019;18:1967-77. [PMID: 32184862 DOI: 10.22037/ijpr.2019.1100800] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Ji D, Luo ZW, Ovcjak A, Alanazi R, Bao MH, Feng ZP, Sun HS. Role of TRPM2 in brain tumours and potential as a drug target. Acta Pharmacol Sin 2022;43:759-70. [PMID: 34108651 DOI: 10.1038/s41401-021-00679-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Guo XM, Yadav MB, Khan M, Hao CW, Lin CY, Huang T, Wu J, Fan BM, Bian ZX. Bradykinin-Potentiating Peptide-Paclitaxel Conjugate Directed at Ectopically Expressed Angiotensin-Converting Enzyme in Triple-Negative Breast Cancer. J Med Chem 2021. [PMID: 34699215 DOI: 10.1021/acs.jmedchem.1c00705] [Reference Citation Analysis]
3 Bojarska J, Remko M, Breza M, Madura I, Fruziński A, Wolf WM. A Proline-Based Tectons and Supramolecular Synthons for Drug Design 2.0: A Case Study of ACEI. Pharmaceuticals (Basel) 2020;13:E338. [PMID: 33114370 DOI: 10.3390/ph13110338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]